Evidence map›Paper›PMID 36640187›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2023

Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial.

Katharina Lechner, Matthias Bock, Clemens von Schacky, Johannes Scherr, Elke Lorenz, Benjamin Lechner, Bernhard Haller, Alexander Krannich, Martin Halle, Rolf Wachter and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Katharina Lechner *Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.ORCID http://orcid.org/0000-0002-3582-3512
Matthias Bock *Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
Clemens von SchackyOmegametrix, Munich, Germany.
Johannes ScherrUniversity Center for Prevention and Sports Medicine, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Elke LorenzKlinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
Benjamin LechnerDepartment of Internal Medicine IV, Ludwig-Maximilians University, Munich, Germany.
Bernhard HallerInstitute of AI and Informatics in Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Alexander KrannichCharité, Universitätsmedizin Berlin, Berlin, Germany.
Martin HalleDZHK (German Centre for Cardiovascular Research), Partner site Munich, Munich Heart Alliance, Munich, Germany.
Rolf WachterClinic and Policlinic for Cardiology, University Hospital Leipzig, Leipzig, Germany.
André Duvinage *DZHK (German Centre for Cardiovascular Research), Partner site Munich, Munich Heart Alliance, Munich, Germany.
Frank Edelmann *Department of Cardiology, Campus Virchow Klinikum (CVK), Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. frank.edelmann@charite.de.
German Centre for Cardiovascular Research · DECharité - Universitätsmedizin Berlin · DEDeutsches Herzzentrum München · DELudwig-Maximilians-Universität München · DETUM Klinikum · DEUniversitätsmedizin Göttingen · DEUniversity of Zurich · CH

Funding

Deutsche Herzstiftung [F/19/18]
6 · The paper itself

Abstract

backgroundIndustrially processed trans-fatty acids (IP-TFA) have been linked to altered lipoprotein metabolism, inflammation and increased NT-proBNP. In patients with heart failure with preserved ejection fraction (HFpEF), associations of TFA blood levels with patient characteristics are unknown.

methodsThis is a secondary analysis of the Aldo-DHF-RCT. From 422 patients, individual blood TFA were analyzed at baseline in n = 404 using the HS-Omega-3-Index

resultsBlood levels of the naturally occurring TFA C16:1n-7t were inversely associated with dyslipidemia, body mass index/truncal adiposity, surrogate markers for non-alcoholic fatty liver disease and inflammation at baseline/12 months. Conversely, IP-TFA C18:1n9t, C18:2n6tt and C18:2n6tc were positively associated with dyslipidemia and isomer C18:2n6ct with dysglycemia. C18:2n6tt and C18:2n6ct were inversely associated with submaximal aerobic capacity at baseline/12 months. No significant association was found between TFA and cardiac function.

conclusionsIn HFpEF patients, higher blood levels of IP-TFA, but not naturally occurring TFA, were associated with dyslipidemia, dysglycemia and lower functional capacity. Blood TFAs, in particular C16:1n-7t, warrant further investigation as prognostic markers in HFpEF. Higher blood levels of industrially processed TFA, but not of the naturally occurring TFA C16:1n-7t, are associated with a higher risk cardiometabolic phenotype and prognostic of lower aerobic capacity in patients with HFpEF.

Indexed as

Cardiovascular DiseasesDyslipidemiasHeart FailureTrans Fatty AcidsFemaleHeart Disease Risk FactorsHumansInfantInflammationMaleRisk FactorsStroke VolumeTrans Fatty AcidsAerobic capacityAtherogenic dyslipidemiaCardiac functionDiastolic dysfunctionHeart failureHFpEFTrans-fatty acids

Identifiers

PMID36640187
PMCPMC10584704
OpenAlexW4316096812

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.